Correlation Between Opthea and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Opthea and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Opthea and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and EFFECTOR Therapeutics.
Diversification Opportunities for Opthea and EFFECTOR Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Opthea and EFFECTOR is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Opthea i.e., Opthea and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Opthea and EFFECTOR Therapeutics
If you would invest 0.10 in EFFECTOR Therapeutics on August 28, 2024 and sell it today you would earn a total of 0.00 from holding EFFECTOR Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Opthea vs. EFFECTOR Therapeutics
Performance |
| Timeline |
| Opthea |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Opthea and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opthea and EFFECTOR Therapeutics
The main advantage of trading using opposite Opthea and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.| Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |